Duke Cancer Institute shared on LinkedIn:
“Research led by DCI’s Jennifer Plichta, MD, suggests that some patients with limited metastatic breast cancer may benefit from a more aggressive treatment approach than has traditionally been offered.”
Title: Locally Ablative Therapies in Oligometastatic Breast Cancer
Authors: Tori Nierenberg, Samantha Thomas, Ian Halliday, Astrid Botty van den Bruele, Ton Wang, Laura Rosenberger, Meghan Flanagan, Gayle DiLalla, E. Shelley Hwang, Jennifer Plichta
Read the Full Article on JAMA Surgery.
Other posts about Duke Cancer Institute on OncoDaily.